PureTech Health (PRTC) Change in Account Payables (2020 - 2025)
PureTech Health (PRTC) reported Change in Account Payables of $23.2 million for Q4 2025, down 14.19% year-over-year from $27.0 million in Q4 2024, and up 23.2% quarter-over-quarter from $18.8 million in Q2 2025.
PureTech Health (PRTC) Change in Account Payables (2020 - 2025) Analysis & Trends
PureTech Health (PRTC) has 6 years of Change in Account Payables data on file, last reported at $23.2 million in Q4 2025.
- Change in Account Payables for Q4 2025 came in at $23.2 million, down 14.19% year-over-year; the trailing twelve-month figure through Dec 2025 was $23.2 million (down 14.19% YoY), and the FY2025 annual result was $23.2 million, down 14.19% from the prior year.
- Change in Account Payables grew to $23.2 million in Q4 2025 per PRTC's latest filing, from $18.8 million in the prior quarter.
- Over five years, Change in Account Payables peaked at $54.8 million in Q4 2022 and troughed at $18.8 million in Q2 2025.
- A 5-year average of $33.6 million and a median of $31.4 million in 2024 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2021 and 2025: Change in Account Payables soared 73.88% in 2021, then sank 40.15% in 2025.
- A 5-year view of Change in Account Payables shows it stood at $35.8 million in 2021, then jumped by 53.36% to $54.8 million in 2022, then declined by 19.57% to $44.1 million in 2023, then sank by 38.74% to $27.0 million in 2024, then slipped by 14.19% to $23.2 million in 2025.
- Business Quant data shows PRTC's Change in Account Payables at $23.2 million in Q4 2025, $18.8 million in Q2 2025, and $27.0 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -9.42 Mn |
| 10 | PureTech Health | 86.36 Mn | -190.94 Mn | - | 23.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 23.19 Mn |
| Dec 31, 2025 | 23.19 Mn |
| Jun 30, 2025 | 18.82 Mn |
| Jun 30, 2025 | 18.82 Mn |
| Dec 31, 2024 | 27.02 Mn |
| Dec 31, 2024 | 27.02 Mn |
| Jun 30, 2024 | 31.45 Mn |
| Jun 30, 2024 | 31.45 Mn |
| Dec 31, 2023 | 44.11 Mn |
| Dec 31, 2023 | 44.11 Mn |
| Dec 31, 2022 | 54.84 Mn |
| Dec 31, 2022 | 54.84 Mn |
| Dec 31, 2021 | 35.76 Mn |
| Dec 31, 2021 | 35.76 Mn |
| Dec 31, 2020 | 20.57 Mn |
| Dec 31, 2020 | 20.57 Mn |